Anna Y Khanna, MD
Associate Chair Of Regional Systems Integration, Associate Professor, & Stroke Medical Director
Department:
MD – VASCULAR NEUROLOGY
Business Phone:
(352) 294-5000
Business Email:
anna.khanna@neurology.ufl.edu
About Anna Y Khanna
Anna Khanna, MD, an associate professor of neurology at the University of Florida College of Medicine and is a key member of the only comprehensive stroke program in north central Florida.
Dr. Khanna earned her B.A. in biological sciences from Rutgers University and her MD at Ross University School of Medicine. She completed her preliminary internal medicine residency year at the University of Medicine and Dentistry of New Jersey in 1999 and remained there to complete her neurology residency in 2002. Dr. Khanna became a stroke fellow there, and through its active vascular program, used both medical and endovascular therapies for the treatment of stroke. She completed her fellowship in 2003. She remained on faculty as an assistant professor, stroke program director and a mentor to medical students and residents. Dr. Khanna played an integral role in the community outreach for stroke education and traveled extensively to educate the public. As director of the outpatient stroke clinic and the resident clinic, Dr. Khanna introduced a comprehensive vascular ultrasound examination in the outpatient setting.
Dr. Khanna then joined the faculty at Saint Barnabas University Hospital in Livingston, NJ, where she was the stroke program director and mentored residents in internal medicine by introducing them to the multitude of vascular disorders. In both hospitals, she trained staff, provided continuing medical education and coordinated with the accreditors in their Joint Commission primary stroke center accreditation.
Dr. Khanna moved to Florida in 2007 and joined a private practice, providing general neurology care to the Marion County community. Dr. Khanna joined the faculty at UF as an assistant professor in the neurovascular division in 2011. She is currently providing care for stroke patients in inpatient and outpatient settings. She mentors two stroke fellows, medical students and residents. Dr. Khanna’s main interests are in acute stroke management and continuing research in several clinical trials treating acute stroke.
Teaching Profile
Courses Taught
2021
PAS5020 Intro to Medicine 2
2021
MDC7800 Neurology Clerkship
Board Certifications
-
NeurologyAmerican Board of Psychiatry and Neurology
Clinical Profile
Specialties
- Vascular Neurology
Areas of Interest
- Acute Ischemic Stroke
- Aneurysm
- Brain aneurysm
- Stroke
- Transient ischemic attack
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0003-2808-2645
Publications
2023
Thoracoscopic Left Atrial Appendage Exclusion for Atrial Fibrillation Patients Intolerant to Anticoagulation.
Innovations (Philadelphia, Pa.).
18(2):152-158
[DOI] 10.1177/15569845231163857.
[PMID] 36999676.
2022
Benefits of an interdisciplinary stroke clinic: addressing a gap in physical therapy at post-stroke neurology follow-up.
Disability and rehabilitation.
44(26):8509-8514
[DOI] 10.1080/09638288.2021.2008527.
[PMID] 34871115.
2021
Bilateral Cerebral Hyperperfusion Syndrome Following Carotid Artery Stenting in Stroke – A Case Report.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
30(3)
[DOI] 10.1016/j.jstrokecerebrovasdis.2020.105546.
[PMID] 33333479.
2021
Commentary: Cerebral perfusion computed tomography scan imaging as a warning light.
JTCVS techniques.
10:198-199
[DOI] 10.1016/j.xjtc.2021.10.058.
[PMID] 34984380.
2021
Erratum to “Impact of COVID-19 on Future Ischemic Stroke Incidence” [eNeurologicalSci, 22C (2021) 100325].
eNeurologicalSci.
23
[DOI] 10.1016/j.ensci.2021.100342.
[PMID] 33937535.
2021
Impact of COVID-19 on Future Ischemic Stroke Incidence.
eNeurologicalSci.
22
[DOI] 10.1016/j.ensci.2021.100325.
[PMID] 33553699.
2021
Trajectories of stroke recovery of impairment, function, and quality of life in response to 12-month mobility and fitness intervention.
NeuroRehabilitation.
49(4):573-584
[DOI] 10.3233/NRE-210147.
[PMID] 34806625.
2021
Trends of Acute Ischemic Stroke Reperfusion Therapies from 2012 to 2016 in the United States.
World neurosurgery.
150:e621-e630
[DOI] 10.1016/j.wneu.2021.03.073.
[PMID] 33757890.
2020
Innovative Long-Dose Neurorehabilitation for Balance and Mobility in Chronic Stroke: A Preliminary Case Series.
Brain sciences.
10(8)
[DOI] 10.3390/brainsci10080555.
[PMID] 32824012.
2018
Bilateral Basal Ganglia Necrosis Secondary to Methamphetamine.
Movement disorders clinical practice.
5(5):555-556
[DOI] 10.1002/mdc3.12649.
[PMID] 30515446.
2017
Brain and spinal cord infarcts secondary to an atrial-esophageal fistula.
Neurology. Clinical practice.
7(5):387-389
[DOI] 10.1212/CPJ.0000000000000332.
[PMID] 29620062.
2016
Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.
JAMA neurology.
73(3):308-15
[DOI] 10.1001/jamaneurol.2015.4315.
[PMID] 26747792.
2016
Thoracoscopic Ablation With Appendage Ligation Versus Medical Therapy for Stroke Prevention: A Proof-of-Concept Randomized Trial.
Innovations (Philadelphia, Pa.).
11(2):99-105
[DOI] 10.1097/IMI.0000000000000226.
[PMID] 26914668.
2015
Rare Etiology of Bow Hunter’s Syndrome and Systematic Review of Literature.
Journal of vascular and interventional neurology.
8(3):7-16
[PMID] 26301025.
2015
Recurrence of Lobar Hemorrhage: A Red Flag for Cerebral Amyloid Angiopathy-related Inflammation?
Innovations in clinical neuroscience.
12(5-6):20-6
[PMID] 26155374.
2014
Endovascular treatment of tandem internal carotid and middle cerebral artery occlusions.
Journal of vascular and interventional neurology.
7(4):26-31
[PMID] 25422711.
2014
Isolated middle cerebral artery dissection: a systematic review.
International journal of emergency medicine.
7(1)
[DOI] 10.1186/s12245-014-0044-1.
[PMID] 25593617.
2014
Praxis and writing in a right-hander with crossed aphasia.
Neurocase.
20(3):317-27
[DOI] 10.1080/13554794.2013.770883.
[PMID] 23557340.
2013
Cerebral amyloid angiopathy with asymmetric superficial hemosiderosis and transient focal neurological symptoms.
The Neurohospitalist.
3(2)
[DOI] 10.1177/1941874412474020.
[PMID] 23983893.
2013
Flow failure from intracranial atherosclerotic disease: a rationale for endovascular intervention in a population with recurrent symptoms despite maximal medical therapy.
Journal of neurointerventional surgery.
5(4)
[DOI] 10.1136/neurintsurg-2012-010275.
[PMID] 22661599.
2013
Spontaneous swallowing frequency has potential to identify dysphagia in acute stroke.
Stroke.
44(12):3452-7
[DOI] 10.1161/STROKEAHA.113.003048.
[PMID] 24149008.
2012
Management of tandem occlusion stroke with endovascular therapy.
Neurosurgical focus.
32(5)
[DOI] 10.3171/2012.1.FOCUS11350.
[PMID] 22537125.
Grants
Jan 2023
ACTIVE
CTOA Yuzefovich Khanna
Role: Principal Investigator
Funding: UNIV OF FLORIDA
Aug 2022
ACTIVE
Carotid Revascularization and Medical Management for Asymptomatic Carotid stenosis – Hemodynamics (CREST-H) – Renewal
Role: Principal Investigator
Funding: MAYO CLINIC
via NATL INST OF HLTH NINDS
Apr 2022
ACTIVE
Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial
Role: Principal Investigator
Funding: MAYO CLINIC
Sep 2021
ACTIVE
Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis
Role: Principal Investigator
Funding: UNIV OF CINCINNATI
via NATL INST OF HLTH NINDS
Sep 2021
ACTIVE
Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial
Role: Principal Investigator
Funding: MAYO CLINIC
via NATL INST OF HLTH NINDS
Mar 2020
ACTIVE
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial
Role: Principal Investigator
Funding: UNIV OF CINCINNATI
via NATL INST OF HLTH NINDS
Sep 2019
ACTIVE
StATins Use in intRacerebral hemorrhage patieNts (SATURN) Study"
Role: Principal Investigator
Funding: UNIV OF CINCINNATI
via NATL INST OF HLTH NINDS
Mar 2019
– May 2023
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction
Role: Principal Investigator
Funding: IQVIA Holdings
via BIOGEN MA INC
Sep 2018
– Sep 2023
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial – Hemodynamics (CREST-H).
Role: Principal Investigator
Funding: MAYO CLINIC
Aug 2018
ACTIVE
Sleep for Stroke Management and Recovery Trial (Sleep SMART) Stroke Trial
Role: Principal Investigator
Funding: UNIV OF CINCINNATI
via NATL INST OF HLTH NINDS
Sep 2017
– Jun 2023
Disparities in Transition of Care after Acute Stroke Hospitalization: The Transition of Care Stroke Disparity Study (TCSD-S)
Role: Principal Investigator
Funding: UNIV OF MIAMI
via NATL INST OF HLTH NIMHD
Aug 2017
– Aug 2022
Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry
Role: Principal Investigator
Funding: DUKE UNIVERSITY
via JANSSEN SCIENTIFIC AFFAIRS
Aug 2017
– Nov 2022
Phase 2 Study of Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke – CoBIS 2
Role: Principal Investigator
Funding: DUKE UNIVERSITY MEDICAL CTR
via MARCUS FOU
May 2017
– Apr 2023
Carotid Revascularization and Medical Management for Asymptomatic Carotid stenosis – Hemodynamics (CREST-H)
Role: Principal Investigator
Funding: MAYO CLINIC
via NATL INST OF HLTH NINDS
Feb 2017
– Feb 2019
Mild and Rapidly Improving Stroke Symptoms Research Study (MaRISS)
Role: Principal Investigator
Funding: *SHANDS TEACHING HOSPITAL HEALTHCARE
via AMER HEART ASSOCIATION
Jul 2016
– Jul 2021
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS-986141 for the Prevention of Recurrent Brain Infarction in Subjects receiving Acetylsalicylic Acid (ASA) following Acute Ischemic Stroke or Transient Ischemic Attack
Role: Principal Investigator
Funding: BRISTOL MYERS SQUIBB CO
Mar 2016
– Aug 2024
Carotid Revascularization and Medical management for Asymptomatic Carotid Stenosis Trial (CREST-2) Trial
Role: Principal Investigator
Funding: MAYO CLINIC
via NATL INST OF HLTH NINDS
Mar 2014
– Feb 2021
Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD)
Role: Principal Investigator
Funding: UNIV OF MIAMI
via NATL INST OF HLTH NINDS
Feb 2014
– Feb 2017
SOCRATES Acute Stroke Or Transient IsChaemic Attack TReated with Aspirin or Ticagrelor and Patient OutcomES
Role: Principal Investigator
Funding: ASTRAZENECA
Mar 2013
– Dec 2021
The Surpass IntraCranial Aneurysm Embolization System Pivotal Trial to Treat Large or Giant Wide Neck Aneurysms
Role: Project Manager
Funding: CERSYS
Nov 2012
– Jul 2016
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II)
Role: Principal Investigator
Funding: UNIV OF MINNESOTA
via NATL INST OF HLTH NINDS
Education
Stroke Fellowship
2003
·
University of Medicine and Dentistry of New Jersey
Chief Resident
2002
·
University of Medicine and Dentistry of New Jersey
M.D.
1998
·
Ross University
Contact Details
Phones:
- Business:
- (352) 294-5000
Emails:
- Business:
- anna.khanna@neurology.ufl.edu
Addresses:
- Business Mailing:
-
PO BOX 103715
GAINESVILLE FL 326100001 - Business Street:
-
1329 SW 16TH ST RM 1160
GAINESVILLE FL 32608